Amedisys Reports First Quarter 2021 Financial Results Updates 2021 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Amedisys (AMED) Tops Q1 EPS by 7c
April 28, 2021 4:13 PM EDTAmedisys (NASDAQ: AMED) reported Q1 EPS of $1.50, $0.07 better than the analyst estimate of $1.43. Revenue for the quarter came in at $537.14 million versus the consensus estimate of $544.86 million.
Paul B. Kusserow, Chairman and Chief Executive Officer stated, I am proud of our first quarter results and our continued performance in our four... More



